Printed From BioPortfolio.com
FDA Advisers Back Gene Therapy for Rare form of Blindness
13:22 EDT 13 Oct 2017 | Bioethics.com
(Nature) – Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation. On 12 October, a panel of external … Read More
Original Article: FDA Advisers Back Gene Therapy for Rare form of Blindness
